TP53 and Crohn disease: ATF3 was shown to maintain intestinal barrier regeneration and IEC survival (Yang et al. 2009; Zhou et al. 2017), while it also promotes IEC apoptosis by working with p53 in Crohn’s disease (Gu et al. 2018).